However, our data showed that high expression of ST3GAL5 was associated with poor prognosis of ccRCC patients (Figures 3A, B) and enrichment of CD8+ T cells in ccRCC (Figures 5A-C). The gene discussed is ST3GAL5; the disease is nonpapillary renal cell carcinoma.